A recent meta-analysis by Ravani and colleagues (Ravani, P., et al., Am J Kidney Dis, 2016. 67(3): p. 446-60.) studied the effect of pre-emptive correction of arterio-venous dialysis vascular access versus deferred care, based on data from 11 trials. The authors reported a non-significant protective treatment effect of pre-emptive correction on access loss, while showing a significant protective effect on thrombosis rates conferred by pre-emptive correction. We revisit this analysis, including data extraction and effects of a heterogenous study population.
The creation and maintenance of a well-functioning vascular access is central to dialysis therapy and remains a major concern to the community. Access-related complications and failure are the most common cause of hospitalization in the dialysis population 1 . Close monitoring by the dialysis staff and early intervention in specialized facilities has become the standard-of-care as mandated by K-DOQI, and is widely held to prolong patency and decrease the risk of adverse outcomes. Nevertheless, this approach is not universally accepted to reduce hospitalizations, access thrombosis or access loss, and thus has been the subject of an ongoing debate. Frequent access care and follow-up in free-standing offices has been shown in a large retrospective analysis to result in fewer hospitalizations, lower mortality rates, and decreased incidence of infection, resulting in lower healthcare costs to Medicare 2 . However, the data on close observation in dialysis clinics, frequent follow-ups, and early intervention are limited to a small number of prospective studies that lack adequate power. Prospective studies of subjects receiving treatment with arterio-venous fistula (AVF), arterio-venous graft (AVG), or both, have compared rates of access loss between treatment groups receiving preemptive care, generally based on monitoring and immediate intervention, and control groups where intervention is generally performed only after clinically manifest problems develop with the access [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] .
A systematic literature review and a meta-analysis recently published by Ravani et. al 3 We reviewed all publications used in the meta-analysis of Ravani and colleagues 3 , extracting event counts using the methods reported in the above Cochrane review 15 . This meta-analysis focuses on the outcome of access loss. All studies consider the comparison a treatment group receiving preemptive access correction to a control group receiving deferred correction. Each individual study comprises either a) AVF or b) AVG patients, and no study combines these two patient groups. Random and fixed-effects meta-analysis were performed using risk ratio (RR) and risk difference (RD) as effect measures. In addition to combining both access types in the same fashion as Ravani and colleagues 3 , we analyzed the two dialysis access types separately. S  i  m  u  l  a  t  i  n  g  t  h  e  E  f  f  e  c  t  o  f  H  e  t  e  r  o  g  e  n  e  o  u  s  P  o  p  u  l  a  t  i  o  n  s We employed a hybrid bootstrap / Monte Carlo simulation to demonstrate the impact of mixing heterogeneous populations in the meta-analysis. When mixing heterogeneous patient populations, such as patients with graft access type stenosis where pre-emptive correction has mild or no effect, with patients with fistula access type stenosis where pre-emptive correction has a strong protective effect, the results depend on the arbitrary proportions of the two populations included. This proportion is arbitrary because it depends on the number of studies of each population that have been published. We simulated meta-analyses based on the sample sizes and event probabilities of the original studies included in the meta-analysis by Ravani et al. 3 
, but
where we manipulated the proportion of studies of fistula and graft access type stenosis. In other words, the number of studies was held constant at 11, but the number based on fistula accesstype studies was varied from 0 to 11. Due to the greater effectiveness of preemptive correction on fistula access type stenosis, meta-analysis of intervention effectiveness produces results that are not statistically significant when zero to three fistula-type studies are included, but reach statistical significance for four or more fistula-type studies. The synthesized risk ratio is 0.86(sub exact number) when all studies are graft access type, and 0.50(sub exact number) when all studies are fistula access type (Figure 4) . This exercise demonstrates the arbitrariness of metaanalysis that synthesizes heterogeneous populations where treatment effectiveness differs. Meta-analysis studies must be considered with appropriate caution because they can have significantly different conclusions than subsequent large randomized controlled trials of the same topic 16 . Study heterogeneity can harm the validity of meta-analysis and result in disagreement with gold-standard large randomized controlled trials 16 . This is because there may be biological reasons, statistical evidence, or both, showing that "the studies included in the meta-analysis have in fact measured somewhat different things, so that a combined estimate cannot be meaningful unless additional, doubtful assumptions are made." 17 , There is sound reason to expect pre-emptive correction to be more important for fistula than for grafts access type, given the higher incidence of early onset failure in concert with the substantially superior long-term survival of AVF compared to AVG. In this context the statement by Bailar 17 appears perfectly accurate and it may indeed be hypothesized that high-frequent follow-ups by the vascular surgeon or interventionist shortly after access creation contributes to its survival during the initial high-risk period. AVG accesses tend to fail at a later time point in time, often with severe comorbidities and infections involved, that result in severe complications with access resulting in substantially shorter long-term survival rates for AVG, thus an explanation for the lack of a significant treatment effect of preemptive correction could be the overall condition of the access (and possibly also the patient). For this reason, and the consistent observed difference in treatment effectiveness, we do not believe it is justifiable to present a single estimate of effectiveness that synthesizes AVG and AVF access type. This is consistent with the 11 individual studies analyzed, none of which reported estimates that combined the two access types. 
